Review



fty720 treatment  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    TargetMol fty720 treatment
    Fty720 Treatment, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fty720/Fingolimod/pm41904143-334-2-6
    Average 94 stars, based on 6 article reviews
    fty720 treatment - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    Flow Cytometry:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Irradiation:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Cell Culture:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Two Tailed Test:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    FACS:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Knockdown:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Co-culture Assay:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Co-Culture:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Emulsification:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Animal Model:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Enzyme-linked Immunosorbent Assay:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Expressing:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Comparison:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Control:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Staining:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Immunohistochemical staining:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Derivative Assay:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Standard Deviation:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Transmission Electron Microscopy:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Immunohistochemistry:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    H&E Stain:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Immunofluorescence:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Activation Assay:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Protein-Protein interactions:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Western Blot:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Concentration Assay:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    RNA Sequencing:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Transformation Assay:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Gene Expression:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Construct:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).

    Cell Viability Assay:

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer.
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8+ T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer
    Article Snippet: When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.When tumors reached ~100 mm3 (subcutaneous/fragment) or after bioluminescence confirmed engraftment (orthotopic/metastatic), mice were randomized to receive 15-Gy focal radiation or sham.. In the FTY720 treatment experiments, FTY720 (TargetMol, 162359-55-9) was administered via gavage at 20 μg per dose daily for 7 days.. For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.For CD8 + T cell or macrophage depletion experiments, 200 μg of anti-CD8α (BioXCell, BE0061) or anti-CSF1 (BioXCell, BE0204) antibody was injected intraperitoneally, beginning one day prior to other treatments and continuing twice weekly.

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA). NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University. PLGA was obtained from Evonik Industries AG (Germany). Cellu-SepT4 dialysis bag was purchased from Membrane Filtration Products, Inc. (USA). IMR-90 and Raw264.7 cell lines were purchased from the Bioresource Collection and

    Article Title: Enhancing Lung Recovery: Inhaled Poly(lactic- co -glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
    Article Snippet: FTY720 was purchased from TargetMol Chemicals Inc. (USA).. NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.NOB was provided by Prof. Min-Hsiung Pan from the Institute of Food Science and Technology, National Taiwan University.

    Article Title: The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
    Article Snippet: Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).Sphingosine kinase 1 inhibitor (PF-543) was obtained from MedChemexpress (New Jersey, USA).. TY52156 and FTY720 were bought from TargetMol (USA).



    Similar Products

    fty720  (Selleck Chemicals)
    97
    Selleck Chemicals fty720
    Fty720, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fty720/OF-1/10__1186_slash_s41983___026___01264___4-44-1-2
    Average 97 stars, based on 1 article reviews
    fty720 - by Bioz Stars, 2026-10
    97/100 stars
    		  Buy from Supplier
    fty720  (MedChemExpress)
    97
    MedChemExpress fty720
    Fty720, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fty720/Fingolimod+hydrochloride/pmc13655036-372-0-6
    Average 97 stars, based on 1 article reviews
    fty720 - by Bioz Stars, 2026-10
    97/100 stars
    		  Buy from Supplier
    modulator fty720 targets sphingosine 1 phosphate receptors  (Brinkmann Instruments)
    86
    Brinkmann Instruments modulator fty720 targets sphingosine 1 phosphate receptors
    Modulator Fty720 Targets Sphingosine 1 Phosphate Receptors, supplied by Brinkmann Instruments, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fty720/1+fty720+modulator+phosphate+receptors+sphingosine+targets/pm42268470-257-35-6
    Average 86 stars, based on 1 article reviews
    modulator fty720 targets sphingosine 1 phosphate receptors - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    immunosuppressive drug fty720  (Novartis)
    86
    Novartis immunosuppressive drug fty720
    Immunosuppressive Drug Fty720, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fty720/fty720/pm42041530-19-17-22
    Average 86 stars, based on 1 article reviews
    immunosuppressive drug fty720 - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    sev fty720  (MedChemExpress)
    97
    MedChemExpress sev fty720
    Sev Fty720, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fty720/Fingolimod/pm41981595-84-70-75
    Average 97 stars, based on 1 article reviews
    sev fty720 - by Bioz Stars, 2026-10
    97/100 stars
    		  Buy from Supplier
    fty720  (Brinkmann Instruments)
    86
    Brinkmann Instruments fty720
    Fty720, supplied by Brinkmann Instruments, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fty720/1+receptor+s1p/pm41941276-93-13-17
    Average 86 stars, based on 1 article reviews
    fty720 - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier

    Image Search Results